<DOC>
	<DOCNO>NCT02544919</DOCNO>
	<brief_summary>To study impact pretreatment live donor liver transplantation recipient SMOF lipid incidence severity post-transplantation neurological complication patient receive tacrolimus base immunosuppression protocol</brief_summary>
	<brief_title>Lipids Neurological Complications Liver Transplantation</brief_title>
	<detailed_description>All patient include study receive immuno-suppression protocol base tacrolimus mycophenolate mofetil induction immuno-suppression intra-operative period . Patients full history take full neurological examination 48 hour prior designate operative date basal record . control group receive lipid infusion treatment group receive study emulsion ( SMOF lipid 20 % - Fresenius Kabi ) start 48 hour plan surgery day continue receive 5 post-operative day intravenous infusion . During post-operative period . patient assess daily full neurological examination patient complaint ( symptom ) relate neurological status diagnosis neurological condition ( complication ) might arise study period . Data analyse compare basal value group control intervention group use appropriate statistical test .</detailed_description>
	<criteria>Adult live donor liver transplant recipient either sex MELD score &gt; 30 Retransplantation Budd Chiari syndrome Diabetes 10 year</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>SMOF</keyword>
	<keyword>neurological complication</keyword>
	<keyword>neurotoxicity</keyword>
	<keyword>liver transplantation</keyword>
	<keyword>Lipid emulsion</keyword>
</DOC>